|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 50, S364-S369, April 2009
The role of adaptive T cell immunity in atherosclerosis
Paris Cardiovascular Research Center, INSERM and Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 75015 Paris, France Ziad Mallat is a recipient of a Contrat d'Interface from Assistance Publique-Hôpitaux de Paris. Published, JLR Papers in Press, December 2, 2008.
1 To whom correspondence should be addressed. e-mail: ziad.mallat{at}inserm.fr
There is now solid evidence that T cell adaptive immunity is involved in atherogenesis. While initial studies have focused on the pathogenic arm of the immune response, more recent work clearly suggests an important role for several subsets of regulatory T cells in the protection against lesion development. Here, we review the current knowledge on the role of both pathogenic and regulatory adaptive T cell immunity in atherosclerosis, generated mainly from the study of mouse models of the disease.
Supplementary key words inflammation lymphocytes cytokines Abbreviations: DC, dendritic cell; IL, interleukin; iTreg, induced Treg cell; oxLDL, oxidized LDL; TGF, transforming growth factor
Related Webpages:
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||